Small-Cell Lung Cancer: Integration of Radiation and Immunotherapy for All Stages
Canadian Oncology Today · 2025
DOI: 10.58931/cot.2025.2239 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Oncology Today, 2025. Verfasst von Nathalie Daaboul. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Small cell lung cancer is an aggressive cancer with a poor prognosis. New treatment paradigms have developed with the incorporation of new therapies in the last few years, aiming to improve patient survival. Some emerging therapies include the addition of immunotherapy to chemotherapy. This article provides a practical review of the current and upcoming treatment options for SCLC in both limited and extensive stages, focusing on integrating radiation and immunotherapy.
Zitieren
APA
Daaboul, N. (2025). Small-Cell Lung Cancer: Integration of Radiation and Immunotherapy for All Stages. Canadian Oncology Today. https://doi.org/10.58931/cot.2025.2239
Vancouver
Daaboul N. Small-Cell Lung Cancer: Integration of Radiation and Immunotherapy for All Stages. Canadian Oncology Today. 2025. doi:10.58931/cot.2025.2239
BibTeX
@article{Daaboul2025,
author = {Daaboul, Nathalie},
title = {Small-Cell Lung Cancer: Integration of Radiation and Immunotherapy for All Stages},
journal = {Canadian Oncology Today},
year = {2025},
doi = {10.58931/cot.2025.2239}
}
EUVIMED